Australian federal court rules patent on human gene testing valid.
Mutations of gene BRCA1 increase risk of breast, ovarian cancer.
Cancer advocacy group had challenged biotech companies' right to patent.
Biotech company Myriad Genetics fighting separate challenge in the U.S..
